J. Scott Wolchko - 21 Jul 2022 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
President and CEO, Director
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
Issuer symbol
FATE
Transactions as of
21 Jul 2022
Net transactions value
-$1,088,852
Form type
4
Filing time
25 Jul 2022, 18:18:08 UTC
Previous filing
25 Apr 2022
Next filing
11 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $81,000 +30,000 +7% $2.70 461,546 21 Jul 2022 Direct F1
transaction FATE Common Stock Sale $352,376 -10,829 -2.3% $32.54* 450,717 21 Jul 2022 Direct F1, F2
transaction FATE Common Stock Sale $633,985 -19,171 -4.3% $33.07* 431,546 21 Jul 2022 Direct F1, F3
transaction FATE Common Stock Options Exercise $16,864 +6,246 +1.4% $2.70 437,792 22 Jul 2022 Direct F1
transaction FATE Common Stock Sale $91,578 -2,923 -0.67% $31.33* 434,869 22 Jul 2022 Direct F1, F4
transaction FATE Common Stock Sale $88,145 -2,703 -0.62% $32.61* 432,166 22 Jul 2022 Direct F1, F5
transaction FATE Common Stock Sale $20,634 -620 -0.14% $33.28* 431,546 22 Jul 2022 Direct F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -30,000 -83% $0.000000 6,246 21 Jul 2022 Common Stock 30,000 $2.70 Direct F1, F7
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -6,246 -100% $0.000000* 0 22 Jul 2022 Common Stock 6,246 $2.70 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020.
F2 Represents the weighted average sale price of the shares sold ranging from $31.82 to $32.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6.
F3 Represents the weighted average sale price of the shares sold ranging from $32.83 to $33.33 per share.
F4 Represents the weighted average sale price of the shares sold ranging from $30.99 to $31.74 per share.
F5 Represents the weighted average sale price of the shares sold ranging from $32.02 to $33.01 per share.
F6 Represents the weighted average sale price of the shares sold ranging from $33.03 to $33.67 per share.
F7 This option is fully vested.